Release Date: December 22, 2025
CME Track Expiration Date: December 22, 2026
Pharmacist Track Expiration Date: March 31, 2027
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in the recognition, prevention, and management of oncologic emergencies associated with high-dose methotrexate (HDMTX) treatment. In this educational program, these experts discuss the latest updates in the management of HDMTX, practical strategies for delayed clearance, and toxicity management .
This educational activity is an archive of the live symposium held on December 17, 2025.
Target Audience
This educational activity is directed toward oncologists, hematologists, pharmacists, advanced practice providers (nurse practitioners and physician assistants), and other health care professionals involved in the care of patients receiving high-dose methotrexate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Determine supportive care requirements for patients with cancer receiving treatment with high-dose methotrexate (HDMTX)
- Integrate online clinical support tools such as mtxpk.org to aid identification of delayed methotrexate clearance
- Apply guideline-based recommendations to manage oncologic emergencies in patients with delayed methotrexate clearance following HDMTX administration

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
